(Q40340314)

19 September 2017

title

Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells (English)

1 reference

19 September 2017

Honggang Wang

1

1 reference

19 September 2017

Lin Zhou

2

1 reference

19 September 2017

Anshul Gupta

3

1 reference

19 September 2017

R Robert Vethanayagam

4

1 reference

19 September 2017

Yi Zhang

5

1 reference

19 September 2017

Jashvant D Unadkat

6

1 reference

19 September 2017

Qingcheng Mao

7

1 reference

19 September 2017

publication date

13 December 2005

1 reference

American Journal of Physiology - Endocrinology and Metabolism

19 September 2017

published in

1 reference

19 September 2017

volume

290

1 reference

19 September 2017

issue

5

1 reference

19 September 2017

page(s)

E798-807

1 reference

Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Differential regulation of estrogen receptor (ER)alpha and ERbeta in primate mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Characterization and Functional Properties of the A and B Forms of Human Progesterone Receptors Synthesized in a Baculovirus System

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

A multidrug resistance transporter from human MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Progesterone action in a murine Leydig tumor cell line (mLTC-1), possibly through a nonclassical receptor type

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Regulation of progesterone receptor isoforms expression by sex steroids in the rat lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Breast cancer resistance protein exports sulfated estrogens but not free estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Estrogen receptor expression and growth-promoting function in human choriocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Dose-dependent effects of 4-hydroxytamoxifen, the active metabolite of tamoxifen, on estrogen receptor-alpha expression in the rat uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Progesterone blocks the estradiol-stimulated luteinizing hormone surge by disrupting activation in response to a stimulatory estradiol signal in the ewe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Stimulatory effect of progesterone on the expression of steroidogenic acute regulatory protein in MA-10 Leydig cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Expression and function of estrogen receptor subtypes in granulosa cells: regulation by estradiol and forskolin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00397.2005

10.1152/AJPENDO.00397.2005

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference